Tag

Glp1 Agonists

All articles tagged with #glp1 agonists

health1 year ago

Weighing the Risks: The Truth About Ozempic and Weight Loss Injections

The article discusses the use of GLP1 agonists like Ozempic for weight loss, highlighting concerns about their side effects and the tendency for weight to return after stopping the medication. Dr. Whit Roberts of Health Utah emphasizes the financial and health risks associated with these drugs, noting potential side effects such as nausea, thyroid cancer, and increased visceral fat. He advocates for addressing underlying health issues through personalized evaluations and nutrition rather than relying on medication. Health Utah offers a comprehensive health assessment to tailor weight loss programs without extreme dieting.

health1 year ago

Evaluating Ozempic: Weighing Weight Loss Benefits Against Side Effects

The article discusses the use of GLP1 agonists like Ozempic for weight loss, highlighting concerns about their side effects and the tendency for weight to return after stopping the medication. Dr. Whit Roberts of Health Utah emphasizes the financial and health risks associated with these drugs, noting potential side effects such as nausea, thyroid cancer, and increased visceral fat. He advocates for addressing underlying health issues through personalized evaluations and nutrition rather than relying on medication. Health Utah offers a comprehensive health assessment to tailor weight loss programs to individual needs.

health-medicine1 year ago

"Ozempic and Semaglutide Unveil Surprising Life-Saving Potential, Scientists Find"

A study in Sweden suggests that GLP1 agonists like Ozempic may lower the risk of severe liver diseases such as cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. The research, published in the journal Gut, found that long-term use of these drugs was associated with a reduced likelihood of developing severe liver damage. While the results need to be confirmed in clinical trials, the findings offer a potential new treatment option for preventing severe liver diseases in people with concurrent type 2 diabetes and chronic liver disease.